lopinavir/ritonavir 200/50 mg (generic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for lopinavir/ritonavir 200/50 mg (generic), covering 2020-07-17 to 2020-07-17. Get the full timeline:
Most recent: Clinical Trial Update: TDM of Generic Lopinavir/Ritonavir 200/50 mg [Phase 2]